These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [A comparative analysis of the effect of alpha 2-interferon (reaferon) therapy on the morphofunctional state of the bone marrow in patients with chronic myeloleukemia]. Abdulkadyrov KM; Rukavitsyn OA; Moiseev SI; Rugal' VI Gematol Transfuziol; 1993 Mar; 38(3):11-3. PubMed ID: 8020725 [TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effectiveness of the Russian drug reaferon in hairy cell leukemia]. Grigor'eva MA; Polianskaia AM Gematol Transfuziol; 1990 Jun; 35(6):16-9. PubMed ID: 2203666 [TBL] [Abstract][Full Text] [Related]
6. [Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia]. Abdulkadyrov KM; Moiseev SI; Shcherbakova EG; Balashova VA; Glazanova TV; Rukavitsyn OA; Martynkevich IS; Gritsaev SV; Blinov MN Ter Arkh; 1995; 67(6):59-63. PubMed ID: 7667786 [TBL] [Abstract][Full Text] [Related]
7. [Use of interferon inducers and reaferon in the combined therapy of acute viral hepatitis B]. Andreĭchin MA; Rudchik AS; Borak VF Ter Arkh; 1988; 60(11):29-32. PubMed ID: 3238572 [TBL] [Abstract][Full Text] [Related]
8. Cell sensitivity to reaferon in patients with renal cell cancer after reaferon therapy. Shkapova EA; Kurtasova LM; Savchenko AA Bull Exp Biol Med; 2007 Jul; 144(1):80-2. PubMed ID: 18256759 [TBL] [Abstract][Full Text] [Related]
9. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia]. Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942 [TBL] [Abstract][Full Text] [Related]
10. [Recombinant human alfa2-interferon (reaferon) in ointment form in the treatment of various diseases of the skin and mucosa]. Parfenov VV; Grebeniuk VN; Abramova EI; Voronin IuV; Bumialis VV; Volodina TN; Denisov LA Antibiot Khimioter; 1990 Sep; 35(9):38-40. PubMed ID: 2275591 [TBL] [Abstract][Full Text] [Related]
11. [The effect of recombinant alfa-2 interferon (reaferon) on the functional activity of natural killers in acute viral hepatitis B]. Petrovskaia IA; Kushko LIa; Fedorchenko SV; Vovk AD; Listopad NK; Antoniak SN; Drannik GN Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):56-7. PubMed ID: 8553758 [No Abstract] [Full Text] [Related]
12. [Comparative results of therapy with amizon and reaferon of patients with chronic viral hepatitis B and C and kidney complications]. Kominko LV Lik Sprava; 2003; (2):81-4. PubMed ID: 12774484 [TBL] [Abstract][Full Text] [Related]
13. [Antitumor effect of the Soviet recombinant alpha2-interferon (reaferon) under experimental conditions]. Lavrukhina LA; Posevaia TA; Barinskiĭ IF; Ershov FI Vopr Virusol; 1989; 34(3):312-5. PubMed ID: 2477953 [TBL] [Abstract][Full Text] [Related]
14. [Alpha-2a-interferon (Reaferon) in the treatment of patients with multiple myeloma]. Bessmel'tsev SS; Abdulkadyrov KM Vopr Onkol; 1999; 45(4):393-7. PubMed ID: 10532098 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon]. Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238 [TBL] [Abstract][Full Text] [Related]
16. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration]. Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904 [TBL] [Abstract][Full Text] [Related]
17. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585 [TBL] [Abstract][Full Text] [Related]
18. [Effect of reaferon on the functional activity of peripheral blood lymphocytes and neutrophils of volunteers]. Gabrilovich DI; Serebrovskaia LV; Murzabaeva RT; Semashko MI; Zmyzgova AV Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):61-5. PubMed ID: 3389006 [TBL] [Abstract][Full Text] [Related]
19. [Experience in treating patients with hairy-cell leukemia with a Soviet genetically engineered interferon]. Lepkov SV; Kruglova GV; Volkova MA; Demina EA Ter Arkh; 1989; 61(7):133-6. PubMed ID: 2588131 [No Abstract] [Full Text] [Related]
20. [The use of reaferon in treating patients with protracted viral hepatitis]. Kokoreva LN; Zmyzgova AV; Nazarenko IV Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]